Trading Signals: BAX Stock Price Prediction and Forecast (Mon. Dec. 1, 2014 - Wed. Sep. 27, 2023)(Baxter International Inc.)
| BAX latest price $45.3600 (2.02%) ($44.7900 - $45.5300) on Fri. Jun. 16, 2023. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.78% (three month average) | RSI | 70 | Latest Price | $45.3600(2.02%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | BAX advances 1.6% a day on average for past five trading days. | Weekly Trend | BAX advances 3.7% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support BAX advance at 0% a week (0% probability) ARKG(26%) ACES(25%) XLRE(24%) ARKK(23%) BWX(22%) | Factors Impacting BAX price | BAX will decline at least -0.89% in a week (0% probabilities). MCHI(-24%) KWEB(-24%) FXI(-23%) EEM(-15%) VWO(-14%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.89% (StdDev 1.78%) | Hourly BBV | 1.4 () | Intraday Trend | 0.2% | | | |
|
5 Day Moving Average | $43.89(3.35%) | 10 Day Moving Average | $42.83(5.91%) | 20 Day Moving Average | $42.24(7.39%) | To recent high | -4.9% | To recent low | 20.7% | Market Cap | $23.142b | | | | Baxter International, Inc. provides portfolio of essential renal and hospital products, including acute and chronic dialysis, sterile IV solutions, infusion systems and devices, parenteral nutrition therapies; premixed and oncolytic injectable, bio surgery products and anesthetics, drug reconstitution systems; and pharmacy automation, software and services. It operates through the following segment: Americas, Europe, Middle East & Africa and Asia-Pacific. The company was founded by Davis Baxter in 1931 and is headquartered in Deerfield, IL. |